
Drugs, anti-angiogenesis: <a href="https://www.medicinenet.com/cancer/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">Cancer</a> cells secrete angiostatin and Endostatin, which halt the process of developing new blood vessels (angiogenesis).  Developing new blood vessels is a rate-limiting step in <a href="https://www.medicinenet.com/tumor_grade/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">tumor</a> growth.  Angiostatin is a piece of a larger protein, plasminogen, that the body uses in blood clotting.  This explains why cancer patients have a higher rate of <a href="https://www.medicinenet.com/blood_clots/article.htm" onclick="wmdTrack('embd-lnk');" rel="dt">blood clots</a>.